期刊文献+

慢性丙型肝炎经抗病毒治疗后获得持续病毒学应答患者发生肝细胞癌危险因素预测分析 被引量:3

Risk factors for occurrence of post-sustained virologic response hepatocellular carcinoma in chronic hepatitis C ;patients
原文传递
导出
摘要 目的:研究慢性丙型肝炎(CHC)抗病毒获得持续病毒学应答(SVR)后发生肝细胞癌(HCC)的危险因素和预测模型。方法收集2006年1月至2014年12月郑州大学第一附属医院感染病科因 CHC 入院且抗病毒后获得 SVR 的住院患者共203例,其中 SVR 后 HCC 患者11例;应用 Cox 比例风险回归模型研究 SVR 后 HCC 的危险因素。应用受试者工作特征曲线(ROC)确定危险因素预测SVR 后 HCC 的截断值。结果在 Cox 模型中,与初始诊断 HCV 感染时疾病阶段为 CHC 相比,初始诊断为代偿期肝硬化患者的 SVR 后 HCC 风险增加9.4倍;SVR 时白蛋白水平每升高1 g/L,SVR 后HCC 的风险降低20%。SVR 时白蛋白水平预测 SVR 后 HCC 的截断值为≤36.0 g/L,ROC 曲线下面积为0.809。基于初始诊断 HCV 感染时疾病阶段为代偿期肝硬化和 SVR 时白蛋白≤36.0 g/L 基础上建立了 SVR 后 HCC 预测模型,其 ROC 曲线下面积为0.871,敏感度、特异度和阴性预测值分别为0.818、0.896和0.989。结论初始诊断 HCV 感染时为代偿期肝硬化和 SVR 时白蛋白≤36.0 g/L 是SVR 后 HCC 的危险因素,且可较好地预测 SVR 后 HCC 的发生风险。 Objective To investigate the risk factors and predictive model for the occurrence of post-sustained virologic response (SVR)hepatocellular carcinoma in chronic hepatitis C (CHC)patients. Methods A total of 203 CHC patients hospitalized at the First Affiliated Hospital of Zhengzhou University from January 2006 to December 2014 who received antiviral therapy and achieved SVR were collected,including 11 post-SVR HCC cases.Risk factors for post-SVR HCC were estimated by Cox′s proportional hazards regression model.Cutoff value predicting risk of post-SVR HCC was determined by receiver operating characteristic curve.Results In Cox′s model,the risk of post-SVR HCC increased by 9.4-fold in patients with initial diagnosis as compensated cirrhosis compared to those with initial diagnosis as CHC.Increase in post-SVR albumin by per 1 g/L was associated with reduced risk by 20% for the occurrence of post-SVR HCC.Cut-off value of post-SVR albumin for the prediction of HCC was determined as ≤ 36.0 g/L with an area under the curve (AUC)of 0.809.A predictive model for post-SVR HCC was created based on initial diagnosis as compensated cirrhosis and post-SVR albumin ≤36.0 g/L with an AUC of 0.871 .The sensitivity,specificity and negative predictive value of the model were 0. 818,0.896 and 0.989,respectively.Conclusions Initial diagnosis as compensated cirrhosis combines with post-SVR albumin ≤36.0 g/L are risk factors for post-SVR HCC with ideal prediction value for the occurrence of post-SVR HCC in CHC patients.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2016年第3期160-165,共6页 Chinese Journal of Infectious Diseases
基金 国家自然科学基金(81302593) 河南省高等学校重点科研项目(15A320083)
关键词 队列研究 肝炎 丙型 慢性 肝细胞 危险因素 持续病毒学应答 Cohort studies Hepatitis C,chronic Carcinoma,hepatocellular Risk Factors Sustained virologic response
  • 相关文献

参考文献2

二级参考文献14

  • 1康来仪,孙永德,郝连杰,曹学义,潘启超.我国丙型和戊型肝炎人群流行病学调查及流行因素的研究[J].中华传染病杂志,1997,15(2):71-75. 被引量:99
  • 2D.Lavanchy.Evolving epidemiology of hepatitis C virus[J]. Clinical Microbiology and Infection . 2011 (2)
  • 3Chiara Giordanino,Simone Ceretto,Simona Bo,Antonina Smedile,Alessia Ciancio,Elisabetta Bugianesi,Rinaldo Pellicano,Sharmila Fagoonee,Elisabetta Versino,Giuseppe Costa,Daniele Arese,Marco Sacco,Mario Rizzetto,Giorgio Saracco.Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study[J]. Digestive and Liver Disease . 2011 (5)
  • 4European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1)
  • 5Mark G. Swain,Ming–Yang Lai,Mitchell L. Shiffman,W. Graham E. Cooksley,Stefan Zeuzem,Douglas T. Dieterich,Armand Abergel,Mário G. Pess?a,Amy Lin,Andreas Tietz,Edward V. Connell,Moisés Diago.A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin[J].Gastroenterology.2010(5)
  • 6Raxitkumar Jinjuvadia,Suthat Liangpunsakul,Fadi Antaki.Past Exposure to Hepatitis B: A Risk Factor for Increase in Mortality?[J].Journal of Clinical Gastroenterology.2014(3)
  • 7Lars Haukali Omland,Peter Jepsen,Henrik Krarup,Kristian Sch?nning,Bent Lind,Hans Kromann–Andersen,Keld Mikkelsen Homburg,Peer Brehm Christensen,Henrik Toft S?rensen,Niels Obel.Increased Mortality Among Persons Infected With Hepatitis C Virus[J].Clinical Gastroenterology and Hepatology.2011(1)
  • 8J.Grebely,J. D.Raffa,C.Lai,T.Kerr,B.Fischer,M.Krajden,G. J.Dore,M. W.Tyndall.Impact of hepatitis C virus infection on all‐cause and liver‐related mortality in a large community‐based cohort of inner city residents[J].Journal of Viral Hepatitis.2010(1)
  • 9Yuki Kita,Eishiro Mizukoshi,Toshinari Takamura,Masaru Sakurai,Yoshiko Takata,Kuniaki Arai,Tatsuya Yamashita,Yasunari Nakamoto,Shuichi Kaneko.Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus[J].Metabolism.2007(12)
  • 10Chiung M.Chen,Young‐HeeYoon,Hsiao‐yeYi,Diane L.Lucas.Alcohol and Hepatitis C Mortality Among Males and Females in the United States: A Life Table Analysis[J].Alcoholism: Clinical and Experimental Research.2007(2)

共引文献226

同被引文献61

  • 1丙型肝炎防治指南[J].中华内科杂志,2004,43(7):551-555. 被引量:106
  • 2Trepo C. A brief history of hepatitis milestones [ J]. Liver Int, 2014, 34( Suppl 1 ) :29-37.
  • 3Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [J]. Science, 1989, 244 (4902) : 359-362.
  • 4Webster DP, Klenerman P, Dusheiko GM. Hepatitis C [J]. Lancet, 2015, 385(9973) :1124-1135.
  • 5Kohli A, Shaffer A, Sherman A, et al. Treatment of hepatitis C: a systematic review [J]. JAMA, 2014, 312(6) :631-640.
  • 6World Health Organization. Hepatitis C [ Online]. http://www, who. int/mediacentre/factsheets/fs164/en/ [ cited 2016 Jul 201.
  • 7Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians [ On- line], http://www, cdc. gov/mmwr/pdf/wk/ mm6218, pdf [ cited 2016 Jul 201.
  • 8Alter M J, Kuhnert WL, Finelli L, et al. Guidelines for laboratory tes- ting and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention [J]. MMWR Recomm Rep, 2003, 52 (RR-3) :1-13, 15.
  • 9European Association for Study of Liver. EASL Clinical Practice Guide- lines: management of hepatitis C virus infection [ J ]. J Hepatol, 2014, 60(2 ) :392-420.
  • 10Westbrook RH, Dusheike G. Natural history of hepatitis C [ J ]. J Hepatol, 2014, 61 ( 1 Suppl) : S58-S68.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部